Revvity cut its 2024 revenue forecast as reduced biotech spending and a strong dollar weigh on demand for its tools and ...

Arcellx has shared several data cuts on anito-cel, a CAR-T being developed with Gilead’s Kite Pharma to treat relapsed or ...

Sports San Diego is a nonprofit that runs the Holiday Bowl and began promoting the city for global sports events in 2022. It ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

The shop is drawing customers to Connecticut’s upscale Gold Coast shoreline, where shopping draws customers from across the ...

Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...

Changpeng Zhao, founder of Binance Holdings Litd, attends the Viva Technology conference dedicated to innovation and ...

Aurinia has announced a 45% workforce reduction to bolster sales of the lupus drug Lupkynis and advance the development of ...

Although the COP16 summit in Colombia ended with some important agreements, countries still aren’t moving fast enough to stem biodiversity loss ...

Market Analysis of Hypercalcemia Treatment Market from 2018 to 2022 vs. Market Outlook for 2023 to 2033 The ... The emergence of many biotech firms for conducting research and development on ...

The global bioprocess containers and fluid transfer solutions market is poised for substantial growth, with an expected ...

Anavex Life Sciences' (AVXL) stock surged on new Alzheimer's trial data, but data's inconsistency raises concerns, making the ...